Stock Tracker: Price Target Review on Shares of salesforce.com, inc. (NYSE:CRM)

Monitoring some price target data, we have noticed that shares of salesforce.com, inc. (NYSE:CRM) currently have an average target of $170.71. This number is the consensus target price averaging estimates provided by analysts polled by Zacks Research. Sell-side analysts have various methods at their disposal for estimating stock price targets. Many investors will closely monitor stock target prices, especially when Street analysts change their view on a specific target price. Some investors may follow these sell-side targets very closely and use the provided information to assist with their own stock research.

Investors often have to calculate risk/reward scenarios when navigating the equity market. Keeping track of alternatives and gauging the likelihood of certain outcomes can help with designing a legitimate strategy. When all the research and planning has been completed, there may come a time when the investor has to make a decision and get ready to take some action. There will obviously be some trades that work out great and others that don’t. Accepting the fact that this is part of the process can help keep the investor focused on the next trade instead of lamenting the past.

We can now shift the focus to some company earnings data. Based on projections provided by 31 individual Wall Street analysts polled by Zacks Research, salesforce.com, inc. (NYSE:CRM) has a current quarter EPS consensus estimate of 0.62. For the prior reporting period, the company posted quarterly earnings per share of 0.61. As earnings season continues, investors will be closely tracking analyst estimates. Sell-side analysts often make updates before and after the company reports earnings numbers. Following analyst estimate updates leading up to the earnings release may offer some good insight into the direction that the estimates are trending. Investors will be watching to see which companies post the largest earnings surprises this quarter.

Taking a look at the current consensus broker rating for salesforce.com, inc. (NYSE:CRM), we note that the ABR is 1.13. This Zacks consensus rating follows a numerical scale where a number in the 1-2 range generally represents a Buy, a 3 would indicate a Hold and 4-5 signals a Sell rating. In terms of the number of bullish analysts that have the stock rated a Buy or Strong Buy, we can see that the number is currently 29.

Investors may be following some historical price data on shares of salesforce.com, inc. (NYSE:CRM). Over the past 12 weeks, the stock has seen a change of 29.03%. If we go back to the beginning of the year, we can see that shares have changed 16.43%. Over the last 4 weeks, shares have seen a change of 6.44%. Over the last 5 trading sessions, the stock has moved 2.93%. Investors will be monitoring stock activity over the next few weeks to try and gauge which way the momentum is leaning. Checking on some possible support and resistance levels, we have noted that that the 52-week high is currently $162.79, and the 52-week low is currently $107.69. When shares are trading close to the 52-week high or 52-week low, investors might be paying added attention. Looking at some recent action, we note that the stock has been seen trading near the $159.47 mark.

Stock market investors may be taking some time to review portfolio allocation. Rebalancing the portfolio may be necessary for some but not for others. Rebalancing the portfolio may help provide a strategy for when the market becomes highly volatile. This process may also help keep the investor buying low and selling high. Investors may also be looking at some different stocks to explore in the next few months. This may include reviewing some foreign markets or some new sectors that were previously not included in the stock portfolio. Completing all the necessary research is typically a good way to start building a more comprehensive pool of diversified stocks.    

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.